Brussels, 17/07/2012 (Agence Europe) - On 17 July, the European Commission adopted a draft regulation to boost clinical research in Europe. Clinical trials are vital to develop medicines and to improve and compare the use of already authorised medicines. Clinical trials, however, are undermined by a lengthy and opaque authorisation process. The commissioner for health and consumer policy, John Dalli, said that cutting bureaucracy would be sweeping but not to the detriment of patient safety,...